BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 1901221)

  • 1. Comparative molecular topography of botulinum neurotoxins from Clostridium butyricum and Clostridium botulinum type E.
    Singh BR; Giménez JA; DasGupta BR
    Biochim Biophys Acta; 1991 Mar; 1077(1):119-26. PubMed ID: 1901221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes associated with the nicking and activation of botulinum neurotoxin type E.
    Singh BR; DasGupta BR
    Biophys Chem; 1990 Oct; 38(1-2):123-30. PubMed ID: 2085647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.
    Kozaki S; Onimaru J; Kamata Y; Sakaguchi G
    Infect Immun; 1991 Jan; 59(1):457-9. PubMed ID: 1987060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular topography and secondary structure comparisons of botulinum neurotoxin types A, B and E.
    Singh BR; DasGupta BR
    Mol Cell Biochem; 1989 Mar; 86(1):87-95. PubMed ID: 2755458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium butyricum neurotoxin: partial amino acid sequence of major proteolytic fragments and intracellular activity in PC12 cells.
    Giménez J; Lomneth R; DasGupta BR
    Toxicon; 1994 Sep; 32(9):1137-46. PubMed ID: 7801349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quaternary structure of botulinum and tetanus neurotoxins as probed by chemical cross-linking and native gel electrophoresis.
    Ledoux DN; Be XH; Singh BR
    Toxicon; 1994 Sep; 32(9):1095-104. PubMed ID: 7801345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial amino acid sequences of botulinum neurotoxins types B and E.
    Schmidt JJ; Sathyamoorthy V; DasGupta BR
    Arch Biochem Biophys; 1985 May; 238(2):544-8. PubMed ID: 3888113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular differences between type A botulinum neurotoxin and its toxoid.
    Singh BR; DasGupta BR
    Toxicon; 1989; 27(4):403-10. PubMed ID: 2728029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C. botulinum neurotoxin types A and E: isolated light chain breaks down into two fragments. Comparison of their amino acid sequences with tetanus neurotoxin.
    DasGupta BR; Foley J
    Biochimie; 1989; 71(11-12):1193-200. PubMed ID: 2517479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the molecular topography of the light and heavy chains of type A botulinum neurotoxin following their separation.
    Singh BR; DasGupta BR
    Biophys Chem; 1989 Nov; 34(3):259-67. PubMed ID: 2611349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of botulinum neurotoxin types A and E in aqueous and nonpolar solvents by Fourier transform infrared, second derivative UV absorption, and circular dichroic spectroscopies.
    Singh BR; Wasacz FM; Strand S; Jakobsen RJ; DasGupta BR
    J Protein Chem; 1990 Dec; 9(6):705-13. PubMed ID: 2073322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin.
    Kamata Y; Kimura Y; Hiroi T; Sakaguchi G; Kozaki S
    Biochim Biophys Acta; 1993 Feb; 1156(2):213-8. PubMed ID: 8427878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.
    Zhou Y; Sugiyama H; Johnson EA
    Appl Environ Microbiol; 1993 Nov; 59(11):3825-31. PubMed ID: 8285687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the neurotoxin isolated from a Clostridium baratii strain implicated in infant botulism.
    Giménez JA; Giménez MA; DasGupta BR
    Infect Immun; 1992 Feb; 60(2):518-22. PubMed ID: 1730484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of the Genomes and Neurotoxins of Strains of
    Brunt J; van Vliet AHM; Carter AT; Stringer SC; Amar C; Grant KA; Godbole G; Peck MW
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932818
    [No Abstract]   [Full Text] [Related]  

  • 17. Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form.
    Dekleva ML; Dasgupta BR
    J Bacteriol; 1990 May; 172(5):2498-503. PubMed ID: 2185224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type E Botulinum Neurotoxin-Producing Clostridium butyricum Strains Are Aerotolerant during Vegetative Growth.
    Camerini S; Marcocci L; Picarazzi L; Iorio E; Ruspantini I; Pietrangeli P; Crescenzi M; Franciosa G
    mSystems; 2019; 4(2):. PubMed ID: 31058231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin.
    Prabakaran S; Tepp W; DasGupta BR
    Toxicon; 2001 Oct; 39(10):1515-31. PubMed ID: 11478959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity.
    Shone CC; Hambleton P; Melling J
    Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.